Bzbs

Bzbs has been studied in 2 papers since 2025: none in people yet, 1 in animals, 1 review. The research so far is in animals. The newest paper, Feb 21, 2025: “Senescent alveolar type II epithelial cells-secreted GDF15 promotes silicosis progression via interfering intercellular communication”.

Intervention

2 papers study it1 findingUpdated

See all 2 papers on bzbs

At a glance

The findings reach mice, none yet in people. 1 lab in 1 country.

Mice: a single group. Cells, worms or flies and humans: nothing yet.
  • 1 lab in 1 country
  • Funder: National Natural Science Foundation of China
  • Animals1

What did studies of bzbs find?

1

Studies of bzbs measured one outcome, pulmonary fibrosis.

Pulmonary fibrosis

downin A. model1

1 study
  1. Bzbs decrease pulmonary fibrosis in A. model.

    “lipid nanoparticles targeting GDF15 or cell senescence inhibitor NMN and BZBS showed efficient anti-fibrotic effects in vivo.”

    Animals

    Senescent alveolar type II epithelial cells-secreted GDF15 promotes silicosis progression via interfering intercellular communication

    Ecotoxicology and environmental safety

More on Pulmonary fibrosis

Latest